United States:
FDA Reopens Comment Period For Feedback On Improving The OTC Monograph Process
To print this article, all you need is to be registered or login on Mondaq.com.
In the July 1, 2014, Federal Register, FDA reopened the comment
period for the notice of public hearing, originally published in
the February 24, 2014, Federal Register, requesting comments on how
to improve or alter the current Over-the-Counter ("OTC")
Monograph Process for reviewing nonprescription drugs marketed
under OTC Drug Review. Comments are now due July 31,
2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...